Skip to content

Evaluation of bad news disclosure protocol in cancer patients

Evaluation of the bad news disclosure protocol and the impact of the implementation of the protocol on life expectancy, stress, anxiety and depression of cancer patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240118060721N1
Enrollment
80
Registered
2024-03-15
Start date
2024-04-02
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer. C00-C97

Interventions

Intervention 1: Intervention group:The intervention includes the implementation of the bad news disclosure protocol. In this method, cancer patients who are not aware of their diagnosis will be implem

Sponsors

Tarbiat Modares University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Definitive diagnosis of one type of cancer based on pathology results unawareness of cancer diagnosis Not suffering from mental illness according to the self-report form Age above 18 years

Exclusion criteria

Exclusion criteria: Incomplete questionnaires Failure to participate in the first preparation session

Design outcomes

Primary

MeasureTime frame
Life Expectency. Timepoint: Before the intervention - 3 months after the intervention. Method of measurement: Schneider's 12-item questionnaire.

Secondary

MeasureTime frame
Stress. Timepoint: Before the intervention - one month after the intervention. Method of measurement: Short questionnaire with 21 questions DASS-21.;Anxiety. Timepoint: Before the intervention - one month after the intervention. Method of measurement: Short questionnaire with 21 questions DASS-21.;Depression. Timepoint: Before the intervention - one month after the intervention. Method of measurement: Short questionnaire with 21 questions DASS-21.;Life expectancy. Timepoint: Before the intervention -Three month after the intervention. Method of measurement: Schneider's 12-item questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmitra khobi

Tarbiat Modares University

nilofaroladrostam@gmail.com+98 21 8288 3554

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026